PMC:4331680 / 35361-35698 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4331680","sourcedb":"PMC","sourceid":"4331680","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4331680","text":"Table 6 The gene set enrichment analysis results for the AML network motifs\nAnnotation cluster Enrichment source Involving genes % of the total genes\nGO_BP cellular process 15 93.75%\nGO_CC intracellular 15 93.75%\nGO_MF protein binding 15 93.75%\nKEGG Acute myeloid leukemia 16 100.00%\nKEGG Pathways in cancer 16 100.00%","divisions":[{"label":"label","span":{"begin":0,"end":7}},{"label":"caption","span":{"begin":9,"end":76}},{"label":"p","span":{"begin":9,"end":76}},{"label":"tr","span":{"begin":77,"end":153}},{"label":"th","span":{"begin":77,"end":95}},{"label":"th","span":{"begin":97,"end":114}},{"label":"th","span":{"begin":116,"end":131}},{"label":"th","span":{"begin":133,"end":153}},{"label":"tr","span":{"begin":154,"end":189}},{"label":"td","span":{"begin":154,"end":159}},{"label":"td","span":{"begin":161,"end":177}},{"label":"td","span":{"begin":179,"end":181}},{"label":"td","span":{"begin":183,"end":189}},{"label":"tr","span":{"begin":190,"end":222}},{"label":"td","span":{"begin":190,"end":195}},{"label":"td","span":{"begin":197,"end":210}},{"label":"td","span":{"begin":212,"end":214}},{"label":"td","span":{"begin":216,"end":222}},{"label":"tr","span":{"begin":223,"end":257}},{"label":"td","span":{"begin":223,"end":228}},{"label":"td","span":{"begin":230,"end":245}},{"label":"td","span":{"begin":247,"end":249}},{"label":"td","span":{"begin":251,"end":257}},{"label":"tr","span":{"begin":258,"end":299}},{"label":"td","span":{"begin":258,"end":262}},{"label":"td","span":{"begin":264,"end":286}},{"label":"td","span":{"begin":288,"end":290}},{"label":"td","span":{"begin":292,"end":299}},{"label":"td","span":{"begin":300,"end":304}},{"label":"td","span":{"begin":306,"end":324}},{"label":"td","span":{"begin":326,"end":328}}],"tracks":[]}